269 related articles for article (PubMed ID: 35303244)
1. COVID-19 and its impact on the brain and Mind- A conceptual model and supporting evidence.
Saeed SA; Pastis IS; Santos MG
Psychiatr Q; 2022 Mar; 93(1):271-284. PubMed ID: 35303244
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of coronavirus infectious disease 2019-related neurologic diseases.
Klein RS
Curr Opin Neurol; 2022 Jun; 35(3):392-398. PubMed ID: 35283461
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses.
Banerjee D; Viswanath B
Asian J Psychiatr; 2020 Dec; 54():102350. PubMed ID: 33271682
[TBL] [Abstract][Full Text] [Related]
4. Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.
Beach SR; Praschan NC; Hogan C; Dotson S; Merideth F; Kontos N; Fricchione GL; Smith FA
Gen Hosp Psychiatry; 2020; 65():47-53. PubMed ID: 32470824
[TBL] [Abstract][Full Text] [Related]
5. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
6. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms.
Troyer EA; Kohn JN; Hong S
Brain Behav Immun; 2020 Jul; 87():34-39. PubMed ID: 32298803
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic neuropsychiatric symptoms in novel coronavirus disease 2019 (COVID-19) patients: A qualitative review.
Smith CJ; Renshaw P; Yurgelun-Todd D; Sheth C
Front Public Health; 2022; 10():772335. PubMed ID: 36033820
[TBL] [Abstract][Full Text] [Related]
8. The potential impact of Covid-19 on CNS and psychiatric sequels.
Dehghani A; Zokaei E; Kahani SM; Alavinejad E; Dehghani M; Meftahi GH; Afarinesh MR
Asian J Psychiatr; 2022 Jun; 72():103097. PubMed ID: 35405524
[TBL] [Abstract][Full Text] [Related]
9. [Neuropsychiatric Aspects of COVID-19 - A Narrative Overview].
Rittmannsberger H; Barth M; Malik P; Yazdi K
Fortschr Neurol Psychiatr; 2022 Mar; 90(3):108-120. PubMed ID: 34341978
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of Neurological Manifestations in Covid-19: A Review.
Garg RK
Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
[TBL] [Abstract][Full Text] [Related]
11. Neurotropism and Neuropsychiatric Symptomsi in Patients with COVID-19.
Moretti P; Brufani F; Pierotti V; Pomili G; Di Buò A; Giulietti C; Masini F; Tanku V; Bachetti MC; Menculini G; Tortorella A
Psychiatr Danub; 2021 Dec; 33(Suppl 11):10-13. PubMed ID: 34862882
[TBL] [Abstract][Full Text] [Related]
12. Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry.
Abenza Abildúa MJ; Atienza S; Carvalho Monteiro G; Erro Aguirre ME; Imaz Aguayo L; Freire Álvarez E; García-Azorín D; Gil-Olarte Montesinos I; Lara Lezama LB; Navarro Pérez MP; Pérez Sánchez JR; Romero Delgado F; Serrano Serrano B; Villarreal Vitorica E; Ezpeleta Echávarri D
Neurologia (Engl Ed); 2021 Mar; 36(2):127-134. PubMed ID: 33549369
[TBL] [Abstract][Full Text] [Related]
13. [Panic and pandemic: Review of the literature on the links between panic disorder and the SARS-CoV-2 epidemic].
Javelot H; Weiner L
Encephale; 2020 Jun; 46(3S):S93-S98. PubMed ID: 32507556
[TBL] [Abstract][Full Text] [Related]
14. The psychological impact of COVID-19 pandemic on the general population of Saudi Arabia.
Alkhamees AA; Alrashed SA; Alzunaydi AA; Almohimeed AS; Aljohani MS
Compr Psychiatry; 2020 Oct; 102():152192. PubMed ID: 32688022
[TBL] [Abstract][Full Text] [Related]
15. Central Nervous System Manifestations Associated with COVID-19.
Divani AA; Andalib S; Biller J; Di Napoli M; Moghimi N; Rubinos CA; Nobleza CO; Sylaja PN; Toledano M; Lattanzi S; McCullough LD; Cruz-Flores S; Torbey M; Azarpazhooh MR
Curr Neurol Neurosci Rep; 2020 Oct; 20(12):60. PubMed ID: 33128130
[TBL] [Abstract][Full Text] [Related]
16. Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19.
Baller EB; Hogan CS; Fusunyan MA; Ivkovic A; Luccarelli JW; Madva E; Nisavic M; Praschan N; Quijije NV; Beach SR; Smith FA
Psychosomatics; 2020; 61(6):585-596. PubMed ID: 32828569
[TBL] [Abstract][Full Text] [Related]
17. [Neurological Manifestations of COVID-19: Meningoencephalitis and Encephalopathy].
Nakajima H
Brain Nerve; 2020 Oct; 72(10):1031-1037. PubMed ID: 33051388
[TBL] [Abstract][Full Text] [Related]
18. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN; Yoo HJ
J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
[TBL] [Abstract][Full Text] [Related]
19. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V
Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293
[TBL] [Abstract][Full Text] [Related]
20. Encephalitis in Patients with COVID-19: A Systematic Evidence-Based Analysis.
Islam MA; Cavestro C; Alam SS; Kundu S; Kamal MA; Reza F
Cells; 2022 Aug; 11(16):. PubMed ID: 36010650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
